Cellular events in zoster vesicles: relation to clinical course and immune parameters
- PMID: 165243
- DOI: 10.1093/infdis/131.5.509
Cellular events in zoster vesicles: relation to clinical course and immune parameters
Abstract
The cellular responses in zoster vesicles was studied chronologically in 30 patients, some of whom were compromised hosts with disseminated disease. Cell counts were low initially but rose abuptly later. Polymorphonuclear leukocytes predominated at all times in the vesicular fluid and in the cells adherent to the vesicle base. The abrupt rise in the number of cells generally coincided with an abrupt rise in the titer of vesicular interferon; both increases preceded resolution of local infection and cessation of cutaneous dissemination in disseminated disease, but the sequence of the increases was variable. The peak interferon titer correlated with cessation of dissemination better than did peak cell counts, and the timing of the local events contrasted with appearance of complement-fixing antibody, which commonly occurred after the resolution of disease. Possible interpretations are that a few sensitized lymphocytes may initiate the defensive response, produce interferon, and/or produce chemotactic factors that augment the polymorphonuclear response. The appearance of polymorphonuclear cells may be a nonspecific inflammatory response, or these cells or the deeper mononuclear infiltrate seen in biopsies may contribute to the rise in local interferon.
Similar articles
-
Interferon, antibody, and other host factors in herpes zoster.J Clin Invest. 1972 May;51(5):1170-8. doi: 10.1172/JCI106910. J Clin Invest. 1972. PMID: 5020430 Free PMC article.
-
[Characteristics of the complement-fixing antibody response for varicella-zoster virus in patients with herpes zoster].Ann Sclavo. 1977 Nov-Dec;19(6):1133-43. Ann Sclavo. 1977. PMID: 218503 Italian. No abstract available.
-
Should patients with zoster receive zoster immune globulin?JAMA. 1975 Dec 8;234(10):1049-51. JAMA. 1975. PMID: 171458
-
[Reactivation of herpes zoster infection by varicella-zoster virus].Med Pregl. 1999 Mar-May;52(3-5):125-8. Med Pregl. 1999. PMID: 10518396 Review. Croatian.
-
[Immune responses to varicella-zoster virus infection].Nihon Rinsho. 2006 Mar;64 Suppl 3:184-7. Nihon Rinsho. 2006. PMID: 16615464 Review. Japanese. No abstract available.
Cited by
-
Proinflammatory cytokines and matrix metalloproteinases in CSF of patients with VZV vasculopathy.Neurol Neuroimmunol Neuroinflamm. 2016 Jun 13;3(4):e246. doi: 10.1212/NXI.0000000000000246. eCollection 2016 Aug. Neurol Neuroimmunol Neuroinflamm. 2016. PMID: 27340684 Free PMC article.
-
Insights into the pathogenesis of varicella viruses.Curr Clin Microbiol Rep. 2019 Sep;6(3):156-165. doi: 10.1007/s40588-019-00119-2. Epub 2019 Jul 6. Curr Clin Microbiol Rep. 2019. PMID: 32999816 Free PMC article.
-
Human polymorphonuclear leukocyte-mediated cytotoxicity against varicella-zoster virus-infected fibroblasts.J Virol. 1984 Jul;51(1):110-6. doi: 10.1128/JVI.51.1.110-116.1984. J Virol. 1984. PMID: 6328030 Free PMC article.
-
Complement-mediated phagocytosis of herpes simplex virus by granulocytes. Binding or ingestion.J Clin Invest. 1989 Jul;84(1):107-12. doi: 10.1172/JCI114129. J Clin Invest. 1989. PMID: 2544621 Free PMC article.
-
Single-cell immune profiling and validation of PBMCs in the onset of and recovery from herpes zoster.Commun Biol. 2024 Dec 4;7(1):1617. doi: 10.1038/s42003-024-07289-w. Commun Biol. 2024. PMID: 39633072 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources